Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.36 |
| ▸ | CHRNA10 | Q9GZZ6 | 2/20 | 0.36 |
| ▸ | CHRNA9 | Q9UGM1 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL17957152 | 0.98 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL10882384 | 0.93 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| Bromide SCHEMBL130775 | 0.91 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| Hydrochloric Acid SCHEMBL2530402 | 0.91 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL24900970 | 0.90 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| Hydrochloric Acid SCHEMBL31510116 | 0.88 | TSHR (0.68) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL26571694 | 0.88 | TSHR (0.68) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL1263222 | 0.86 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL15253552 | 0.86 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL1476239 | 0.85 | TSHR (0.57) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022182713-A1 | METHODS OF PHOTOGRAFTING TO SURFACE METAL OXIDES | Orthobond Corporation (US) | 2022-09-01 | — | — | WO | claimed |
| US-20220266296-A1 | Methods of Photografting to Surface Metal Oxides | Orthobond Corporation | 2022-08-25 | — | — | US | claimed |
| US-20230055449-A1 | FUNCTIONAL SURFACES | ORTHOBOND CORP (US) | 2023-02-23 | — | — | US | disclosed |
| WO-2022182713-A1 | METHODS OF PHOTOGRAFTING TO SURFACE METAL OXIDES | Orthobond Corporation (US) | 2022-09-01 | — | — | WO | disclosed |
| US-20220266296-A1 | Methods of Photografting to Surface Metal Oxides | Orthobond Corporation | 2022-08-25 | — | — | US | disclosed |
| EP-3525776-B1 | SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS | ORTHOBOND CORP (US) | 2022-01-26 | — | — | EP | disclosed |
| CN-110312507-B | Surfaces with oligomeric or polymeric antimicrobial agents | 奥索邦德公司 | 2021-11-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230055449-A1 | FUNCTIONAL SURFACES | LPO, SELP, SIGLEC7 | TSHR 2514/4885ALDH1A1 3494/4885CYP3A4 1807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.